Valiant Navion™ VNMF3737C59TU (UDI 00763000100667)Recalls & reported problems
Medtronic, Inc. · STENT GRAFT VNMF3737C59TU VAL NAV FF · Class 3 · Implant
All models of Valiant Navion (137)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00763000100667), received between Feb 26, 2019 and Jul 20, 2023 — classified as 4 injuries, 1 malfunction.
The most frequently reported specific device problem is “Leak/Splash” (4 reports).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Recalls naming this device
- Feb 12, 2021Class IOpen, Classified
Due to the presence of type IIIb endoleaks, stent fractures, and stent ring enlargement.
Z-1201-2021 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Most reported problems
Device problems
- Leak/Splash4
- Difficult or Delayed Positioning1
- Migration or Expulsion of Device1
Patient problems
- Insufficient Information3
- Aneurysm1
- Low Blood Pressure/ Hypotension1
- No Clinical Signs, Symptoms or Conditions1
- Rupture1
- Stroke/CVA1
- Thrombus1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionJul 20, 2023Leak/Splash; Leak/Splash
TWO VALIANT NAVION STENT GRAFTS WERE IMPLANTED DURING AN UNKNOWN ENDOVASCULAR PROCEDURE. IT WAS REPORTED VIA CORELAB REVIEW OF CT IMAGES DATED (B)(6) 2020, (B)(6) 2020, (B)(6) 2021, (B)(6) 2021 AND (B)(6) 2022 THAT A TYPE IA ENDOLEAK WAS OBSERVED IN VNMF3737C59TU ((B)(6)). IT WAS NOTED THAT THE TYPE IA ENDOLEAK WAS NEW ON (B)(6) 2020 AND PERSISTENT ON (B)(6) 2020, (B)(6) 2021, (B)(6) 2021 AND (B)(6) 2022. THERE WAS NO STENT RING ENLARGEMENT OBSERVED. FRACTURE AND STENT RING MIGRATION WERE NON-EVALUABLE DUE TO DEVICE OVERLAPS AND CALCIUM PRESENCE. THE MAXIMUM AORTIC DIAMETER WAS 219MM ON (B)(6) 2020, 223MM ON (B)(6) 2020, 244MM ON (B)(6) 2021, 147MM ON (B)(6) 2021 AND 163MM ON (B)(6) 2022. THERE WAS AORTIC ENLARGEMENT OF +25MM NOTICED ON CT TAKEN ON (B)(6) 2021 COMPARED TO THE CT FROM (B)(6) 2020. THE CAUSE OF THE EVENT IS UNDETERMINED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: Aneurysm; No Clinical Signs, Symptoms or Conditions
MAUDE report 17359766 ↗InjuryDec 6, 2022Leak/Splash; Leak/Splash
A VALIANT NAVION STENT GRAFT WAS IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF AN AORTIC ANEURYSM. IT WAS REPORTED ON AN UNKNOWN DATE, FOLLOW UP IMAGING IDENTIFIED AN EXPANDING ABDOMINAL AORTIC ANEURYSM WITH SUSPECTED OCCULT TYPE III ENDOLEAK AND IMPENDING LOSS OF SEAL IN THE RIGHT ILIAC LIMB. APPROXIMATELY 12 MONTHS POST INDEX PROCEDURE ULTRASOUND GUIDED NEEDLE PLACEMENT RIGHT FEMORAL ARTERY, CIRCUMFERENTIAL PLACEMENT OF ENDOANCHORS IN THE ABDOMINAL AORTIC ENDOGRAFT AND PLACEMENT OF A RIGHT ILIAC LIMB EXTENSION WAS COMPLETED. IT WAS REPORTED APPROXIMATELY 12 MONTHS LATER THE PATIENT PRESENTED AND WAS DIAGNOSED WITH A R MCA INFARCT AND HOSPITALIZED. TREATMENT WAS GIVEN AND THE PATIENT HAD A HAEMORRHAGIC CONVERSION WITH ICH, IV EXTENSION AND SAH. THE PATIENT WAS INTUBATED BUT EXTUBATED FOR COMFORT CARE AND THE PATIENT EXPIRED 2 DAYS POST HOSPITALISATION. PER THE PHYSICIAN THE CAUSE OF THE ANEURYSM EXPANSION AND TYPE III ENDOLEAK ARE UNDETERMINED. THE CAUSE OF THE STROKE LEADING TO DEATH WAS NOT PROVIDED.
Patient problems: Insufficient Information; Stroke/CVA
MAUDE report 15922316 ↗InjuryNov 18, 2022Leak/Splash; Migration or Expulsion of Device; Leak/Splash; Migration or Expulsion of Device
VALIANT NAVION STENT GRAFTS WERE IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A TAA. IT WAS REPORTED A CTA PERFORMED 4 DAYS LATER, A POSSIBLE TYPE IA ENDOLEAK WAS NOTED. THE PATIENT RETURNED FOR INTERVENTION JUST UNDER 2 YEARS LATER. IT WAS NOTED THE MOST PROXIMAL AORTIC STENT BEGINS AT THE ZONE 3 ZONE 4 JUNCTION AND DISTALLY THE PATIENTS ENDOVASCULAR STENTING TERMINATES IN THE EXTERNAL ILIAC ARTERIES BILATERALLY. BOTH INTERNAL ILIAC ARTERIES HAD BEEN SACRIFICED. THE PATIENT HAS A SOLITARY RIGHT KIDNEY AND THE PARA VISCERAL AORTA HAS BEEN TREATED WITH STENTING WITH A CHIMNEY GRAFT TO THE RIGHT RENAL ARTERY AND PERISCOPE GRAFT TO THE CELIAC ARTERY AND SUPERIOR MESENTERIC ARTERY. IT HAS BEEN NOTED OVER THE LAST 12-24 MONTHS THAT THE AORTA IN ZONE 3 HAS BEEN PROGRESSIVELY DILATING AND WITH THAT THE PATIENTS ENDOGRAFT MIGRATED FROM PROXIMAL ZONE 3 INTO THE ZONE 3 ZONE FOR JUNCTION. THE PATIENT HAS NOW HAS A 6 CM ZONE 3 THORACIC AORTIC ANEURYSM AND A LARGE ENDOLEAK/ANEURYSM AT THE PROXIMAL LANDING ZONE. THE PATIENT UNDERWENT A ASCENDING AORTIC REPAIR. THE PATIENT HAD DEBRANCHING OF MAJOR VESSELS AND GRAFTING TO THE DESCENDING AORTA WITH SUBSEQUENT REPAIR OF THE REMAINDER OF ASCENDING
Patient problems: Insufficient Information
MAUDE report 15823555 ↗InjuryNov 18, 2022Leak/Splash; Leak/Splash
VALIANT CAPTIVIA STENT GRAFTS WERE IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A THORACIC ANEURYSM. A VALIANT NAVION STENT GRAFT WAS IMPLANTED DUE TO CONTINUED DILATION OF THE AORTIC ANEURYSM 8 YEARS POST THE INDEX PROCEDURE IT WAS REPORTED APPROXIMATELY 8 MONTHS POST THE NAVION PROCEDURE, FOLLOW UP CT DEMONSTRATED A STABLE SMALL ENDOLEAK ADJACENT TO THE DISTAL ASPECT OF THE STENT GRAFT ANTERIORLY WITHIN THE PROXIMAL DESCENDING THORACIC AORTA. CT IMAGING 2 YEARS POST THE NAVION IMPLANT PROCEDURE SHOWED AN INCREASED DENSITY EXTENDING FROM THE ANTERIOR PROXIMAL MARGIN OF THE STENT WITH EXTENSION INTO THE INFERIOR ASPECT OF THE EXCLUDED ANEURYSM SAC CONSISTENT WITH A TYPE I ENDOLEAK. ON (B)(6) 2022 INTERVENTION WAS COMPLETED. NON MDT STENTS WERE IMPLANTED TO RESOLVE THE ENDOLEAK. PER THE PHYSICIAN THE CAUSE OF THE ENDOLEAK IS UNDETERMINED. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.
Patient problems: Insufficient Information
MAUDE report 15822460 ↗InjuryFeb 26, 2019Difficult or Delayed Positioning; Difficult or Delayed Positioning
A VALIANT NAVION STENT GRAFT SYSTEM WAS IMPLANTED FOR THE ENDOVASCULAR TREATMENT OF A 64MM AN INFRA-RENAL ANEURYSM IN CONJUNCTION WITH A NON MDT DEVICE. IT WAS NOTED THE PATIENT HAD SEVERELY DISEASED BILATERAL ILIACS THROUGHOUT. IT WAS REPORTED DURING THE INDEX PROCEDURE THE RIGHT ILIAC WAS PRE-DILATED WITH NON MDT 7 AND 8 MM BALLOONS. AFTER DEPLOYMENT OF THE NON MDT DEVICE THE PHYSICIAN ATTEMPTED TO ADVANCE THE NAVION DEVICE (B)(4). THE DEVICE WOULD NOT TRACK UP SO THE ILIAC WAS DILATED AGAIN WITH AN 8MM BALLOON AND ALTHOUGH A TIGHT FIT THE DEVICE DID TRACK. AFTER DEPLOYMENT OF THE GRAFT BUT BEFORE THE RELEASE OF THE TIP CAPTURE THE PHYSICIAN FELT A POP AND AT THIS POINT A RAPID DECREASE IN THE PATIENT'S BLOOD PRESSURE WAS NOTED. THE PROXIMAL BARE SPRINGS WERE DEPLOYED HOWEVER UPON REMOVAL OF THE DELIVERY SYSTEM SOME OF THE PATIENT'S BLOOD VESSEL WERE OBSERVED TO BE ATTACHED TO THE DELIVERY SYSTEM. AN INTRA-OPERATIVE ARTERIOGRAM WAS PERFORMED AND A RUPTURE AT THE PATIENT'S RIGHT EXTERNAL ILIAC WAS OBSERVED. MULTIPLE COVERED STENTS WERE USED IN AN ATTEMPT TO REPAIR THE ARTERY UNSUCCESSFULLY AND THE PHYSICIAN ELECTED TO CONVERT TO AN OPEN REPAIR OF THE RIGHT ILIAC. LIGATION OF THE N
Patient problems: Low Blood Pressure/ Hypotension; Rupture; Thrombus
MAUDE report 8369985 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page